Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
1997 Sept;86(9):956-61
Intravenous heroin induces rapid brain hypoxia and hyperglycemia that precede brain metabolic response
The Food and Drug Administration (FDA) mandates that clinical trials demonstrate the cardiovascular safety of anti-diabetic medications
The molecular responses observed vary according to receptor subtype, peptide concentration, exposure time, cell model, and overall study design, and MTII is employed to characterise melanocortinreceptor signalling rather than to infer defined biological or physiological effects
US$ 21.38
US$ 20.61
US$ 26.82
US$ 28.70
